TY - JOUR
T1 - Challenges in the management of acute peptic ulcer bleeding
AU - Lau, James Y.W.
AU - Barkun, Alan
AU - Fan, Dai Ming
AU - Kuipers, Ernst J.
AU - Yang, Yun Sheng
AU - Chan, Francis K.L.
PY - 2013
Y1 - 2013
N2 - Acute upper gastrointestinal bleeding is a common medical emergency worldwide, a major cause of which are bleeding peptic ulcers. Endoscopic treatment and acid suppression with proton-pump inhibitors are cornerstones in the management of the disease, and both treatments have been shown to reduce mortality. The role of emergency surgery continues to diminish. In specialised centres, radiological intervention is increasingly used in patients with severe and recurrent bleeding who do not respond to endoscopic treatment. Despite these advances, mortality from the disorder has remained at around 10%. The disease often occurs in elderly patients with frequent comorbidities who use antiplatelet agents, non-steroidal anti-inflammatory drugs, and anticoagulants. The management of such patients, especially those at high cardiothrombotic risk who are on anticoagulants, is a challenge for clinicians. We summarise the published scientific literature about the management of patients with bleeding peptic ulcers, identify directions for future clinical research, and suggest how mortality can be reduced.
AB - Acute upper gastrointestinal bleeding is a common medical emergency worldwide, a major cause of which are bleeding peptic ulcers. Endoscopic treatment and acid suppression with proton-pump inhibitors are cornerstones in the management of the disease, and both treatments have been shown to reduce mortality. The role of emergency surgery continues to diminish. In specialised centres, radiological intervention is increasingly used in patients with severe and recurrent bleeding who do not respond to endoscopic treatment. Despite these advances, mortality from the disorder has remained at around 10%. The disease often occurs in elderly patients with frequent comorbidities who use antiplatelet agents, non-steroidal anti-inflammatory drugs, and anticoagulants. The management of such patients, especially those at high cardiothrombotic risk who are on anticoagulants, is a challenge for clinicians. We summarise the published scientific literature about the management of patients with bleeding peptic ulcers, identify directions for future clinical research, and suggest how mortality can be reduced.
UR - http://www.scopus.com/inward/record.url?scp=84878646830&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84878646830&partnerID=8YFLogxK
U2 - 10.1016/S0140-6736(13)60596-6
DO - 10.1016/S0140-6736(13)60596-6
M3 - Review article
C2 - 23746903
AN - SCOPUS:84878646830
SN - 0140-6736
VL - 381
SP - 2033
EP - 2043
JO - The Lancet
JF - The Lancet
IS - 9882
ER -